Evidence map›Paper›PMID 39817056›Full record

ReviewJACC. Advances2024

Promoting Global Cardiovascular Health to Advance the Sustainable Development Agenda.

Shanthi Mendis, Ian Graham, Asmus Hammerich, Bente Mikkelsen, Maryam Kavousi, Ramesh Pathirana, Evgeny Zheleznyakov, Jagat Narula

Abstract readReview
In one paragraph

Review in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shanthi MendisGeneva Learning Foundation, Geneva, Switzerland.
Ian GrahamTrinity College Dublin, Dublin, Ireland.
Asmus HammerichDirector, UHC/Noncommunicable Diseases & Mental Health, WHO Eastern Mediterranean Regional Office (EMRO), Nasr City, Cairo, Egypt.
Bente MikkelsenUHC/Communicable and Noncommunicable Diseases, World Health Organization Headquarters, Geneva, Switzerland.
Maryam KavousiDepartment of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Ramesh PathiranaMinistry of Health, Colombo, Sri Lanka.
Evgeny ZheleznyakovWorld Health Organization Regional Office for Africa, World Health Organization, São Tomé and Príncipe, Africa.
Jagat NarulaUniversity of Texas Health Sciences Center, Houston, Texas, USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The burden of cardiovascular disease has declined in high-income countries in the past 3 decades but is growing in low- and middle-income countries due to epidemiological, demographic, and socioeconomic shifts. A range of cost-effective policies and interventions are available for advancing cardiovascular health (CVH) through primordial, primary, and secondary prevention. We showcase multifaceted challenges that stifle the global progress of CVH including shortcomings in financial protection, health systems, primary health care, national health policies, service coverage, and surveillance. We highlight the under-acknowledged global disparities in health expenditure and health workforce capacities. We emphasize the need of addressing social and commercial determinants of health and a more granular analysis of challenges to implement context-appropriate national CVH responses, particularly in low- and middle-income countries. Finally, we propose progressive realization of universal health coverage and national health policy reform as sustainable strategies for overcoming the barriers to achieve CVH in order to reduce premature mortality from noncommunicable diseases by one-third by 2030 (Sustainable Development Goal target 3.4).

Indexed as

cardiovascular diseasecardiovascular healthinequalitiesnoncommunicable diseasesprimary health caresocial and commercial determinants of healthuniversal health coverage

Identifiers

PMID39817056
PMCPMC11734026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.